etoposide has been researched along with Carcinoma, Adenosquamous in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (36.36) | 18.2507 |
2000's | 5 (45.45) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ichi, T; Ishikawa, K; Kawabata, T; Kawasaki, H; Taira, N; Yohena, T | 1 |
Lee, DW; Lee, HN; Lee, KH; Lee, YS; Park, EK; Park, JS | 1 |
Blessing, JA; Buller, RE; Mannel, RS; Rose, PG; Webster, KD | 1 |
Ivanov, S; Zervoudis, S | 1 |
Nishiura, K; Obata, H; Okugawa, T; Tabata, T; Tanaka, K; Toyoda, N; Yanoh, K | 1 |
Ikeba, K; Kimura, M; Kinoshita, K; Maeda, H; Ohkubo, T; Sodemoto, T; Suwata, J; Suzuki, Y; Takagi, A; Takeda, S; Yamamoto, T | 1 |
Fukuda, K; Hara, K; Iwasaka, T; Nakao, Y; Sugimori, H; Uchiyama, M; Yokoyama, M | 1 |
Hatae, M; Hiura, M; Hoshiai, H; Ikeda, M; Izumi, R; Noda, K; Ogita, Y; Okada, H; Ozaki, M; Ozawa, M; Tamaya, T; Tanaka, K; Yamabe, T | 1 |
Craffey, M; Dowlati, A; Levitan, N; MacKay, W; McKenney, J; Remick, SC; Tahsildar, H | 1 |
Fujita, T; Hayashi, T; Higashihara, J; Irie, T; Ohishi, Y; Shigematsu, T | 1 |
Angelelli, B; Bovicelli, A; Ceccarelli, C; Costa, S; Erzén, M; Lipponen, P; Martoni, A; Santini, D; Syrjänen, K; Syrjänen, S; Terzano, P | 1 |
5 trial(s) available for etoposide and Carcinoma, Adenosquamous
Article | Year |
---|---|
Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Hysterectomy; Kaplan-Meier Estimate; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Paclitaxel; Proportional Hazards Models; Radiotherapy, Adjuvant; Survival Rate; Uterine Cervical Neoplasms | 2011 |
Prolonged oral etoposide in recurrent or advanced non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Carcinoma, Adenosquamous; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Uterine Cervical Neoplasms | 2003 |
[Late phase II trial of oral etoposide administered for 21 consecutive days in patients with cervical cancer. ETP 21 Study Group--Cervical Cancer Group].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Alopecia; Antineoplastic Agents, Phytogenic; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Nausea; Uterine Cervical Neoplasms; Vomiting | 1998 |
A brief intensive cisplatin-based outpatient chemotherapy regimen with filgrastim and megestrol acetate support for advanced non-small cell lung cancer: results of a phase II trial.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appetite Stimulants; Carcinoma, Adenosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Megestrol Acetate; Mesna; Middle Aged; Protective Agents; Recombinant Proteins; Survival Analysis; Treatment Outcome | 1998 |
CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.
Topics: Adenocarcinoma; Adult; Aged; alpha Catenin; Antineoplastic Combined Chemotherapy Protocols; beta Catenin; Biomarkers, Tumor; Bleomycin; Cadherins; Carcinoma, Adenosquamous; Cisplatin; Cytoskeletal Proteins; Disease-Free Survival; Epirubicin; Etoposide; Female; Glycoproteins; Humans; Hyaluronan Receptors; Hysterectomy; Immunohistochemistry; Middle Aged; Neoadjuvant Therapy; Survival Rate; Trans-Activators; Uterine Cervical Neoplasms | 2001 |
6 other study(ies) available for etoposide and Carcinoma, Adenosquamous
Article | Year |
---|---|
Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide followed by surgery for thymic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Neoadjuvant Therapy; Retrospective Studies; Thymectomy; Thymoma; Thymus Neoplasms; Treatment Outcome; Vincristine | 2014 |
[Metastatic cancer in transposed ovaries after radical Wertheim-Meigs hysterectomy for a stage I B and II A cervical cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Mitomycin; Neoplasm Staging; Ovarian Neoplasms; Ovary; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Cisplatin; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Hysterectomy; Lymphatic Metastasis; Middle Aged; Mitomycin; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Pilot Projects; Radiotherapy, Adjuvant; Statistics as Topic; Treatment Outcome; Uterine Cervical Neoplasms; Women's Health | 2004 |
[Two cases of adenosquamous cell carcinoma of advanced cervical cancer treated by carboplatin-based chemotherapy with peripheral blood stem cell autotransplant].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Administration Schedule; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Uterine Cervical Neoplasms | 1997 |
Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Middle Aged; Mitomycin; Neoplasm Staging; Uterine Cervical Neoplasms | 1998 |
Metastatic carcinoma in a transposed ovary after radical hysterectomy for a stage 1B cervical adenosquamous cell carcinoma. Case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Mitomycin; Ovarian Neoplasms; Ovariectomy; Ovary; Uterine Cervical Neoplasms | 2000 |